Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06698328 · ClinicalTrials.gov registry record · NA
fMRI Tracking taVNS in ASD
A NA study of Autistic Spectrum Disorders, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06698328: Completed NA study of Autistic Spectrum Disorders, sponsored by Medical University of South Carolina.
NCT06698328 is a NA study of Autistic Spectrum Disorders that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06698328, a NA study of Autistic Spectrum Disorders, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore whether a non-invasive form of ear stimulation called transcutaneous auricular vagus nerve stimulation (taVNS) can manage symptoms in patients with autism spectrum disorder (ASD). Additionally, this study also uses magnetic resonance imaging (MRI) to capture images of participants' brains and apply an image processing method called INSCAPE to track brain state changes during taVNS treatment in ASD. Investigators will recruit up to 16 participants with ASD.
Primary Outcome
Assessing adverse outcomes via qualitative questionnaire asking participants about experiences during stimulation and any consequences after stimulation.
Conditions Studied
Interventions
- DEVICE Transauricular Vagus Nerve Stimulation
- DEVICE Sham Stimulation
Study Locations (1)
South Carolina
- 30 Bee Street - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-02-10 |
| Est. Completion | 2026-02-02 |
| Phase | NA |
What the finished NCT06698328 record still lists
NCT06698328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Autistic Spectrum Disorders appearing as the primary indexed condition, and to 2 interventions - of which Transauricular Vagus Nerve Stimulation is the first listed.
NCT06698328 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06698328 about?
NCT06698328 is a clinical study titled "fMRI Tracking taVNS in ASD". The purpose of this study is to explore whether a non-invasive form of ear stimulation called transcutaneous auricular vagus nerve stimulation (taVNS) can manage symptoms in patients with autism spectrum disorder (ASD). Additionally, this study also uses magnetic resonance imaging (MRI) to capture i...
What is the current status of trial NCT06698328?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2025-02-10. Estimated completion is 2026-02-02.
What conditions does trial NCT06698328 study?
This clinical trial studies the following conditions: Autistic Spectrum Disorders.
What interventions are being tested in trial NCT06698328?
The interventions under investigation include: Transauricular Vagus Nerve Stimulation (DEVICE), Sham Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06698328?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06698328 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06698328's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI